Review

Current Therapeutic Approaches to Chronic Central Serous Chorioretinopathy

• Samet Gülkaş
• Özlem Şahin

Is There a Relationship Between Use of Anti-Vascular Endothelial Growth Factor Agents and Atrophic Changes in Age-Related Macular Degeneration Patients?

• Süleyman Kaynak
• Mahmut Kaya
• Derya Kaya

Original Article

Non-infectious Intraocular Inflammation Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection

• Mahmut Kaya
• Ferit Hakan Öner
• Betül Akbulut Yağcı
• Ferdane Ataş
• Taylan Öztürk

Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization

• Müge Çoban Karataş
• Gürsel Yılmaz
• Aslıhan Yüce Sezen
• Çağla Sarıtürk

The Effects of Anti-Vascular Endothelial Growth Factor Drugs on Retinal Pigment Epithelial Cell Culture

• Mustafa Şahiner
• Dilek Bahar
• Ayşe Öner
• Zeynep Burçin Gönen
• Metin Ünlü
• Duygu Gülmez Sevim
• Çağatay Karaca
• Galip Ertuğrul Mirza

Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study, Bosphorus Retina Study Group Report No: 1

• Abdullah Özkaya
• Levent Karabaş
• Cengiz Alagöz
• Zeynep Alkın
• Özgür Artunay
• Selim Bölükbaşı
• Gökhan Demir
• Mehmet Demir
• Ali Demircan
• Burak Erden
• Gürkan Erdoğan
• Mehmet Erdoğan
• Erdem Eriş
• Havva Kaldırım
• İsmail Umut Onur
• Özen Osmanbaşoğlu
• Sezin Özdoğan Erkul
• Mine Öztürk
• İrfan Perente
• Kübra Sarıcı
• Nihat Sayın
• Dilek Yaşa
• İhsan Yılmaz
• Zeynep Yılmazabdurrahmanoğlu

Risk-based Algorithm-guided Treatment Protocol for the Management of Neovascular Age-related Macular Degeneration

• Murat Karaçorlu
• Mümin Hocaoğlu
• Serra Arf
• M. Giray Ersöz
• Işıl Sayman Muslubaş

Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration

• Mine Esen Barış
• Jale Menteş
• Filiz Afrashi
• Serhad Nalçaçı
• Cezmi Akkın

The Efficacy and Safety of Intravitreal Dexamethasone Implant for the Treatment of Macular Edema Related to Retinal Vein Occlusion: Real-life Data and Prognostic Factors in a Turkish Population

• Ayşe Yağmur Kanra
• Aylin Ardagil Akçakaya
• Sevil Arı Yaylalı
• Meltem Güzin Altınel
• Neslihan Sevimli

Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1

• Uğur Yayla
• Mehmet Orkun Sevik
• Veysel Levent Karabaş
• Özlem Şahin
• Abdullah Özkaya
• Nursal Melda Yenerel
• Banu Açıkalın Öncel
• Fatih Bilgehan Kaplan
• Ecem Önder Tokuç
• Hatice Selen Kanar
• Işıl Kutlutürk Karagöz
• Ece Başaran Emengen
• Ayşe Demirciler Sönmez
• Aslan Aykut
• Utku Limon
• Erdinç Bozkurt
• Işılay Özsoy Saygın
• Tuğba Aydoğan Gezginaslan
• Özlem Aydın Öncü
• Esra Türkseven Kumral
• Nimet Yeşim Erçalık
• Erkan Çelik

Case Report

Unusual Association of Inverse Retinitis Pigmentosa, Scleromalacia, and Neovascular Glaucoma

• Ayşe Gül Koçak Altıntaş
• Çağrı İlhan
• Mehmet Çıtırık

Original Article

Factors Affecting Compliance to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Age-Related Macular Degeneration

• Onur Polat
• Sibel İnan
• Serkan Özcan
• Mustafa Doğan
• Tuncay Küsbeci
• Güliz Fatma Yavaş
• Ümit Übeyt İnan